Plenary Speakers

   Dr. Atul Ambekar   
   National Drug Dependence Treatment Centre   
   AIIMS, 
New Delhi, India   

Dr. Atul Ambekar is an addiction psychiatrist, working as a professor at the prestigious National Drug Dependence Treatment Centre (NDDTC), AIIMS, New Delhi. He divides his time between clinical care, teaching, training, research, and public health program activities. He is a passionate advocate of evidence-informed alcohol and drug policies and programmes.

He has authored a number of publications including research papers, practice guidelines, and training manuals. He has been providing his expertise to many national and international agencies including UNODC, WHO, and INCB. Epidemiology is another area close to his heart, and he has recently concluded the largest national survey on alcohol and drugs in India.

   Dr. Wei Hao   
   Mental Health Institute, Central South University   
    Changsha, China   

Dr. Wei Hao is a Professor of Psychiatry in Mental Health Institute, Second Xiangya Hospital of Central South University, Changsha, China. He is also the Director of the World Health Organization (WHO) Collaborating Centre for Psychosocial Factors, Substance Abuse and Health.

Dr. Hao is a Member of WHO Expert Advisory Panel on Drug Dependence and Alcohol Problems (2006-present); and a Member of the Working Group on the Classification of Substance Abuse for the eleventh revision of the International Classification of Diseases (ICD-11), WHO (2011-present). Further on, he is the President of Chinese Association of Drug Abuse Prevention and Treatment (2015-present) and First-Vice President of International Narcotics Control Board of United Nations (2017, 2019).

   Dr Amy O’Donnell   
   Population Health Sciences Institute  
   Newcastle University, UK   

Dr. Amy O’Donnell is a UK National Institute for Health Research (NIHR) Advanced Fellow at the Population Health Sciences Institute, Newcastle University, UK. Her work focuses on advancing the implementation of evidence-based substance use interventions in global healthcare systems.

A keen advocate for innovative, interdisciplinary approaches, Dr. O’Donnell has specific expertise in mixed-methods research, evidence synthesis techniques, and implementation science.

A member of the INEBRIA Coordinating Committee and Associate Editor for Alcohol and Alcoholism, her current portfolio includes the NIHR ADEPT study (Using complexity science and digital technology to improve co-morbid Alcohol

use disorder and DEpression Prevention and Treatment), and the Horizon 2020 SCALA study, which seeks to improve care for patients with co-morbid heavy drinking and depression in Latin America.

Previously, Dr. O’Donnell led the UK arm of the European ATTUNE project, which explored factors shaping amphetamine-use pathways over the life course, worked on the Cochrane Review of Digital Interventions for Heavy Drinking, the EU BISTAIRS project, and held a Visiting Fellowship in Implementation Science at Linkoping University, Sweden

   Dr Pratima Murthy   
   Department of Psychiatry   
   NIMHANS, Bangalore, India   

Professor Pratima Murthy heads the Department of Psychiatry at NIMHANS, Bangalore, where she earlier headed the Centre for Addiction Medicine.

 

A clinician, trainer and researcher primarily in addiction and mental health, she has edited several manuals on addiction treatment and management and has been an international trainer for the WHO, UNODC and ILO in tobacco, alcohol and other drug cessation. She is involved in mCessation initiatives for tobacco, virtual training through the ECHO, as well as post graduate training and research in these areas.

 

She also works in forensic psychiatry, human rights of the mental ill and documentation of the history of psychiatry.

   Prof Kypros Kypri   
   School of Medicine and Public Health   
   University of Newcastle, Australia   

Professor Kypros Kypri is a behavioural scientist interested in the evaluation of policies and interventions to reduce alcohol-related harm. He was trained in psychology and public health at the University of New South Wales, the University of California San Diego, and the University of Otago, New Zealand. He is a Professor at the School of Medicine & Public Health, University of Newcastle, Australia, where he teaches clinical epidemiology. In 2020, he was seconded to the regional public health unit to provide research support for the COVID-19 response in New South Wales.

   Prof Sven Andreasson   
  Department of Global Public Health   
   Karolinska Institutet, Stockholm, Sweden   

Sven Andréasson, MD, PhD

Professor at the department of Global Public Health at Karolinska Institutet, Stockholm

Senior consultant at the Stockholm Centre for addiction. Senior advisor at the Swedish National Board of Health and Welfare. Chairman of the Swedish Alcohol Policy Forum.

Former president of INEBRIA 2015-2020. His research deals with the epidemiology, prevention and treatment of alcohol and drug related disorders.

   Prof Kate Conigrave   
 University of Sydney, Sydney, Australia   

Kate Conigrave is an addiction medicine physician and public health physician.  Her clinical work is at Royal Prince Alfred Hospital in Sydney, Australia and at the Aboriginal Medical Service Cooperative, Redfern. Kate is a conjoint Professor at the University of Sydney and joint director of the Centre of Research Excellence in Indigenous Health and Alcohol. This Centre focuses on building pathways for Aboriginal and Torres Strait Islander people to lead the way in alcohol research.  Kate has been an author on over 140 journal articles. She chaired the committee which recently revised Australia’s drinking guidelines.

Setting new directions for brief interventions

  • White Facebook Icon
  • White Twitter Icon
  • White Instagram Icon